Spotlight News

View spotlighted releases on a broad range of topics including scientific research, new faculty, VGTI Florida’s Scientific Advisory Board, community outreach and educational initiatives in St. Lucie County including The Summer Undergraduate Research Foundation (SURF) Program, grants, funding and philanthropy, special speaker series, strategic partnerships, intellectual property and publications. VGTI Florida® welcomes media inquires and can arrange tours and interviews for qualified journalists with Principal Investigators on a range of topics with advance notice.

Roseann Gregory Cancer Foundation Presents $35,000 in Donations

By: VGTI Florida®
Source: Roseann Gregory Foundation
Date: May 19, 2014
The Roseann Gregory Cancer Foundation (RGCF) recently gave $35,000 to several local organizations. The funds given were raised during the Foundation’s 3rd Gala in February. The organizations receiving funds included HANDS St. Lucie, Harbour Branch Oceanographic Foundation FAU, IRSC Foundation, Martin Health Foundation and VGTI Florida. The checks were presented during a wine and cheese reception held at VGTI Florida on Monday, May 12th. RGCF was created in 2011 with a mission to provide funds to local organizations to assist cancer patients, as well as to help fund better treatments for cancer and an eventual cure. To learn more about RGCF, visit the organizations Facebook page or their website www.roseanngregory.org.
Categories: Spotlight News
Roseann Gregory Cancer Foundation Presents $35,000 in Donations

Richard Jove, Ph.D., President and Director of VGTI Florida, will present a webinar titled “Emergence of Stem-Like Cells in Prostate Cancer Drug Resistance” for the Life Sciences South Florida (LSSF) group, sponsored by Florida International University.
Categories: Spotlight News
Webinar on Precision Medicine Approach to Prostate Cancer Therapies Presented by President and Director of VGTI Florida

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida) hosted a delegation of medical scientists from the Karolinska Institutet for a research symposium titled “Innovative Approaches to Treating the Diseases of Aging”, held on February 5th-6th, 2014. Karolinska Institutet in Stockholm, Sweden, is world renowned for bestowing the annual Nobel Prize in Physiology or Medicine. Over the course of two days, researchers from VGTI Florida and Karolinska University, along with guest speakers from across North America, presented on topics that focus on diseases of aging. The symposium was one of the first steps that VGTI Florida is taking towards developing the Center for Diseases of Aging (CDA) at their location in Port St. Lucie, FL. The CDA will be a platform for scientists from VGTI Florida to find solutions to health issues in the aging population in collaboration with scientists from Karolinska Institutet and other medical research institutions around the world...
Categories: Spotlight News

When Your Immune System Ages

By: Pat Dimond, Ph.D.
Source: Genetic Engineering News
Date: December 17, 2013
Approximately 90% of influenza-associated deaths occur among adults aged greater than or equal to 65 years. [© GodMaker - Fotolia.com] Influenza remains a major public health issue around the world, with seasonal influenza accounting for approximately 20,000 deaths in the U.S. per year. Among older individuals who are most susceptible to flu-related disease and mortality, a 2010 Morbidity and Mortality Report (MMWR) found that during seasons when influenza A (H3N2) viruses were prominent death rates were more than double what they were during seasons when influenza A (H1N1) or influenza B viruses predominated. Additionally, the study confirmed previous findings that approximately 90% of influenza-associated deaths occur among adults aged greater than or equal to 65 years. An estimated annual average of 124 persons aged less than 19 years and 2,385 aged 19–64 years die from influenza-associated respiratory or circulatory causes. But the older individuals, those most susceptible...
Categories: Spotlight News

Rafael Cubas, Ph.D., of the Vaccine & Gene Therapy Institute of Florida (VGTI Florida) is one of six researchers selected to receive a prestigious grant from The Foundation for AIDS Research (amfAR). amfAR announced the 2013 recipients of the Mathilde Krim Fellowships in Basic Biomedical Research on Thursday, November 21.
Categories: Spotlight News
VGTI Florida® Receives A Prestigious Grant From The Foundation For AIDS Research (amfAR)

VGTI Florida Awarded Lead on Prestigious HIV Grant

By: VGTI Florida®
Date: July 31, 2013
Port St. Lucie, FL – July 29, 2013 – The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) is pleased to announce the award of a grant from the Foundation for AIDS Research (amfAR) in their amfAR Research Consortium on HIV Eradication (ARCHE) program to an international collaboration lead by Principal Investigator Dr. Nicolas Chomont, PhD of VGTI Florida. The collaboration will involve important contributions by scientists at the University of California, San Francisco, the National Institutes of Health Vaccine Research Center, the Thai Red Cross (Thailand), Institut Pasteur (France) and the University of Sydney (Australia)...
Categories: Spotlight News
VGTI Florida Awarded Lead on Prestigious HIV Grant

VGTI Florida’s COO, Mel Rothberg, at BIO International 2012, shares thoughts on the growing biotechnology and life-science industries in the state of Florida.
Categories: Spotlight News
VGTI Florida’s COO, Mel Rothberg, at BIO International 2012, Shares Thoughts On The Growing Biotechnology...

New VGTI Boss Eager To Take Over Daily Operations July 1, 2013 After establishing a reputation for cutting-edge AIDS research, the Vaccine & Gene Therapy Institute of Florida is working to build an equally strong reputation in cancer research, starting with the hiring of a prominent cancer scientist as its director. “We’re now poised for major growth,” said Richard Jove, the Port St. Lucie nonprofit’s new leader. “Our major expansion is going to be in cancer.”
Categories: Spotlight News
New VGTI Florida's Boss Eager To Take Over Daily Operations On July 1, 2013... We’re Now Poised For Major Growth...